Deals for Juno and Bioverativ put CAR-T and hemophilia in spotlight – Chemical & Engineering News
Chemical & Engineering News |
Deals for Juno and Bioverativ put CAR–T and hemophilia in spotlight
Chemical & Engineering News Sanofi is already involved in rare diseases through its Genzyme business, which conducts R&D in Framingham, Mass. Credit: Sanofi. A photo from Sanofi Genzyme's lab in Framingham, Mass. Sanofi is already involved in rare diseases through its Genzyme … Pharma deals, shutdown pact help stocks set more records Energy and technology companies lead US stocks higher Stocks rise after deal to end government shutdown |
